Global Active Pharmaceutical Ingredient Market Research Report 2022(Status and Outlook)
Report Overview
The Global Active Pharmaceutical Ingredient Market Size was estimated at USD 67774.47 million in 2021 and is projected to reach USD 106475.13 million by 2028, exhibiting a CAGR of 6.67% during the forecast period.
Bosson Research’s latest report provides a deep insight into the global Active Pharmaceutical Ingredient market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Active Pharmaceutical Ingredient Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Active Pharmaceutical Ingredient market in any manner.
Global Active Pharmaceutical Ingredient Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Active Pharmaceutical Ingredient Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
The Global Active Pharmaceutical Ingredient Market Size was estimated at USD 67774.47 million in 2021 and is projected to reach USD 106475.13 million by 2028, exhibiting a CAGR of 6.67% during the forecast period.
Bosson Research’s latest report provides a deep insight into the global Active Pharmaceutical Ingredient market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Active Pharmaceutical Ingredient Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Active Pharmaceutical Ingredient market in any manner.
Global Active Pharmaceutical Ingredient Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Teva
- Novartis
- Pfizer
- Johnson and Johnson
- Mylan
- North China Pharmaceutical Group
- Dr. Reddy’s Laboratories
- Roche
- Aurobindo pharma
- Sun Pharmaceutical Industries
- Boehringer Ingelheim GmbH
- Bayer
- BASF
- DSM
- Zhejiang Medicine
- Biocon
- Johnson Matthey
- Hisun Pharmacy
- Cambrex
- Shandong Xinhua Pharmaceutical
- Lonza group
- Huahai Pharmaceutical
- Haerbin Pharmaceutical Group
- Cipla
- Tian Yao
- Lupin
- North East Pharmaceutical
- Albemarle
- Shandong Lukang Pharmaceutical
- Jiangsu?Hengrui Medicine
- Synthetic API
- Biotech API
- Other
- Chemical
- Deodorant
- Dailylife
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Active Pharmaceutical Ingredient Market
- Overview of the regional outlook of the Active Pharmaceutical Ingredient Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Active Pharmaceutical Ingredient Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Active Pharmaceutical Ingredient
1.2 Key Market Segments
1.2.1 Active Pharmaceutical Ingredient Segment by Type
1.2.2 Active Pharmaceutical Ingredient Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ACTIVE PHARMACEUTICAL INGREDIENT MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Active Pharmaceutical Ingredient Market Size (M USD) Estimates and Forecasts (2017-2028)
2.1.2 Global Active Pharmaceutical Ingredient Sales Estimates and Forecasts (2017-2028)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ACTIVE PHARMACEUTICAL INGREDIENT MARKET COMPETITIVE LANDSCAPE
3.1 Global Active Pharmaceutical Ingredient Sales by Manufacturers (2017-2022)
3.2 Global Active Pharmaceutical Ingredient Revenue Market Share by Manufacturers (2017-2022)
3.3 Active Pharmaceutical Ingredient Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Active Pharmaceutical Ingredient Average Price by Manufacturers (2017-2022)
3.5 Manufacturers Active Pharmaceutical Ingredient Sales Sites, Area Served, Product Type
3.6 Active Pharmaceutical Ingredient Market Competitive Situation and Trends
3.6.1 Active Pharmaceutical Ingredient Market Concentration Rate
3.6.2 Global 5 and 10 Largest Active Pharmaceutical Ingredient Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ACTIVE PHARMACEUTICAL INGREDIENT INDUSTRY CHAIN ANALYSIS
4.1 Active Pharmaceutical Ingredient Industry Chain Analysis
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ACTIVE PHARMACEUTICAL INGREDIENT MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ACTIVE PHARMACEUTICAL INGREDIENT MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Active Pharmaceutical Ingredient Sales Market Share by Type (2017-2022)
6.3 Global Active Pharmaceutical Ingredient Market Size Market Share by Type (2017-2022)
6.4 Global Active Pharmaceutical Ingredient Price by Type (2017-2022)
7 ACTIVE PHARMACEUTICAL INGREDIENT MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Active Pharmaceutical Ingredient Market Sales by Application (2017-2022)
7.3 Global Active Pharmaceutical Ingredient Market Size (M USD) by Application (2017-2022)
7.4 Global Active Pharmaceutical Ingredient Sales Growth Rate by Application (2017-2022)
8 ACTIVE PHARMACEUTICAL INGREDIENT MARKET SEGMENTATION BY REGION
8.1 Global Active Pharmaceutical Ingredient Sales by Region
8.1.1 Global Active Pharmaceutical Ingredient Sales by Region
8.1.2 Global Active Pharmaceutical Ingredient Sales Market Share by Region
8.2 North America
8.2.1 North America Active Pharmaceutical Ingredient Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Active Pharmaceutical Ingredient Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Active Pharmaceutical Ingredient Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Active Pharmaceutical Ingredient Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Active Pharmaceutical Ingredient Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILED
9.1 Teva
9.1.1 Teva Active Pharmaceutical Ingredient Basic Information
9.1.2 Teva Active Pharmaceutical Ingredient Product Overview
9.1.3 Teva Active Pharmaceutical Ingredient Product Market Performance
9.1.4 Teva Business Overview
9.1.5 Teva Active Pharmaceutical Ingredient SWOT Analysis
9.1.6 Teva Recent Developments
9.2 Novartis
9.2.1 Novartis Active Pharmaceutical Ingredient Basic Information
9.2.2 Novartis Active Pharmaceutical Ingredient Product Overview
9.2.3 Novartis Active Pharmaceutical Ingredient Product Market Performance
9.2.4 Novartis Business Overview
9.2.5 Novartis Active Pharmaceutical Ingredient SWOT Analysis
9.2.6 Novartis Recent Developments
9.3 Pfizer
9.3.1 Pfizer Active Pharmaceutical Ingredient Basic Information
9.3.2 Pfizer Active Pharmaceutical Ingredient Product Overview
9.3.3 Pfizer Active Pharmaceutical Ingredient Product Market Performance
9.3.4 Pfizer Business Overview
9.3.5 Pfizer Active Pharmaceutical Ingredient SWOT Analysis
9.3.6 Pfizer Recent Developments
9.4 Johnson and Johnson
9.4.1 Johnson and Johnson Active Pharmaceutical Ingredient Basic Information
9.4.2 Johnson and Johnson Active Pharmaceutical Ingredient Product Overview
9.4.3 Johnson and Johnson Active Pharmaceutical Ingredient Product Market Performance
9.4.4 Johnson and Johnson Business Overview
9.4.5 Johnson and Johnson Active Pharmaceutical Ingredient SWOT Analysis
9.4.6 Johnson and Johnson Recent Developments
9.5 Mylan
9.5.1 Mylan Active Pharmaceutical Ingredient Basic Information
9.5.2 Mylan Active Pharmaceutical Ingredient Product Overview
9.5.3 Mylan Active Pharmaceutical Ingredient Product Market Performance
9.5.4 Mylan Business Overview
9.5.5 Mylan Active Pharmaceutical Ingredient SWOT Analysis
9.5.6 Mylan Recent Developments
9.6 North China Pharmaceutical Group
9.6.1 North China Pharmaceutical Group Active Pharmaceutical Ingredient Basic Information
9.6.2 North China Pharmaceutical Group Active Pharmaceutical Ingredient Product Overview
9.6.3 North China Pharmaceutical Group Active Pharmaceutical Ingredient Product Market Performance
9.6.4 North China Pharmaceutical Group Business Overview
9.6.5 North China Pharmaceutical Group Recent Developments
9.7 Dr. Reddy’s Laboratories
9.7.1 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Basic Information
9.7.2 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Product Overview
9.7.3 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Product Market Performance
9.7.4 Dr. Reddy’s Laboratories Business Overview
9.7.5 Dr. Reddy’s Laboratories Recent Developments
9.8 Roche
9.8.1 Roche Active Pharmaceutical Ingredient Basic Information
9.8.2 Roche Active Pharmaceutical Ingredient Product Overview
9.8.3 Roche Active Pharmaceutical Ingredient Product Market Performance
9.8.4 Roche Business Overview
9.8.5 Roche Recent Developments
9.9 Aurobindo pharma
9.9.1 Aurobindo pharma Active Pharmaceutical Ingredient Basic Information
9.9.2 Aurobindo pharma Active Pharmaceutical Ingredient Product Overview
9.9.3 Aurobindo pharma Active Pharmaceutical Ingredient Product Market Performance
9.9.4 Aurobindo pharma Business Overview
9.9.5 Aurobindo pharma Recent Developments
9.10 Sun Pharmaceutical Industries
9.10.1 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Basic Information
9.10.2 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Product Overview
9.10.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Product Market Performance
9.10.4 Sun Pharmaceutical Industries Business Overview
9.10.5 Sun Pharmaceutical Industries Recent Developments
9.11 Boehringer Ingelheim GmbH
9.11.1 Boehringer Ingelheim GmbH Active Pharmaceutical Ingredient Basic Information
9.11.2 Boehringer Ingelheim GmbH Active Pharmaceutical Ingredient Product Overview
9.11.3 Boehringer Ingelheim GmbH Active Pharmaceutical Ingredient Product Market Performance
9.11.4 Boehringer Ingelheim GmbH Business Overview
9.11.5 Boehringer Ingelheim GmbH Recent Developments
9.12 Bayer
9.12.1 Bayer Active Pharmaceutical Ingredient Basic Information
9.12.2 Bayer Active Pharmaceutical Ingredient Product Overview
9.12.3 Bayer Active Pharmaceutical Ingredient Product Market Performance
9.12.4 Bayer Business Overview
9.12.5 Bayer Recent Developments
9.13 BASF
9.13.1 BASF Active Pharmaceutical Ingredient Basic Information
9.13.2 BASF Active Pharmaceutical Ingredient Product Overview
9.13.3 BASF Active Pharmaceutical Ingredient Product Market Performance
9.13.4 BASF Business Overview
9.13.5 BASF Recent Developments
9.14 DSM
9.14.1 DSM Active Pharmaceutical Ingredient Basic Information
9.14.2 DSM Active Pharmaceutical Ingredient Product Overview
9.14.3 DSM Active Pharmaceutical Ingredient Product Market Performance
9.14.4 DSM Business Overview
9.14.5 DSM Recent Developments
9.15 Zhejiang Medicine
9.15.1 Zhejiang Medicine Active Pharmaceutical Ingredient Basic Information
9.15.2 Zhejiang Medicine Active Pharmaceutical Ingredient Product Overview
9.15.3 Zhejiang Medicine Active Pharmaceutical Ingredient Product Market Performance
9.15.4 Zhejiang Medicine Business Overview
9.15.5 Zhejiang Medicine Recent Developments
9.16 Biocon
9.16.1 Biocon Active Pharmaceutical Ingredient Basic Information
9.16.2 Biocon Active Pharmaceutical Ingredient Product Overview
9.16.3 Biocon Active Pharmaceutical Ingredient Product Market Performance
9.16.4 Biocon Business Overview
9.16.5 Biocon Recent Developments
9.17 Johnson Matthey
9.17.1 Johnson Matthey Active Pharmaceutical Ingredient Basic Information
9.17.2 Johnson Matthey Active Pharmaceutical Ingredient Product Overview
9.17.3 Johnson Matthey Active Pharmaceutical Ingredient Product Market Performance
9.17.4 Johnson Matthey Business Overview
9.17.5 Johnson Matthey Recent Developments
9.18 Hisun Pharmacy
9.18.1 Hisun Pharmacy Active Pharmaceutical Ingredient Basic Information
9.18.2 Hisun Pharmacy Active Pharmaceutical Ingredient Product Overview
9.18.3 Hisun Pharmacy Active Pharmaceutical Ingredient Product Market Performance
9.18.4 Hisun Pharmacy Business Overview
9.18.5 Hisun Pharmacy Recent Developments
9.19 Cambrex
9.19.1 Cambrex Active Pharmaceutical Ingredient Basic Information
9.19.2 Cambrex Active Pharmaceutical Ingredient Product Overview
9.19.3 Cambrex Active Pharmaceutical Ingredient Product Market Performance
9.19.4 Cambrex Business Overview
9.19.5 Cambrex Recent Developments
9.20 Shandong Xinhua Pharmaceutical
9.20.1 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient Basic Information
9.20.2 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient Product Overview
9.20.3 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient Product Market Performance
9.20.4 Shandong Xinhua Pharmaceutical Business Overview
9.20.5 Shandong Xinhua Pharmaceutical Recent Developments
9.21 Lonza group
9.21.1 Lonza group Active Pharmaceutical Ingredient Basic Information
9.21.2 Lonza group Active Pharmaceutical Ingredient Product Overview
9.21.3 Lonza group Active Pharmaceutical Ingredient Product Market Performance
9.21.4 Lonza group Business Overview
9.21.5 Lonza group Recent Developments
9.22 Huahai Pharmaceutical
9.22.1 Huahai Pharmaceutical Active Pharmaceutical Ingredient Basic Information
9.22.2 Huahai Pharmaceutical Active Pharmaceutical Ingredient Product Overview
9.22.3 Huahai Pharmaceutical Active Pharmaceutical Ingredient Product Market Performance
9.22.4 Huahai Pharmaceutical Business Overview
9.22.5 Huahai Pharmaceutical Recent Developments
9.23 Haerbin Pharmaceutical Group
9.23.1 Haerbin Pharmaceutical Group Active Pharmaceutical Ingredient Basic Information
9.23.2 Haerbin Pharmaceutical Group Active Pharmaceutical Ingredient Product Overview
9.23.3 Haerbin Pharmaceutical Group Active Pharmaceutical Ingredient Product Market Performance
9.23.4 Haerbin Pharmaceutical Group Business Overview
9.23.5 Haerbin Pharmaceutical Group Recent Developments
9.24 Cipla
9.24.1 Cipla Active Pharmaceutical Ingredient Basic Information
9.24.2 Cipla Active Pharmaceutical Ingredient Product Overview
9.24.3 Cipla Active Pharmaceutical Ingredient Product Market Performance
9.24.4 Cipla Business Overview
9.24.5 Cipla Recent Developments
9.25 Tian Yao
9.25.1 Tian Yao Active Pharmaceutical Ingredient Basic Information
9.25.2 Tian Yao Active Pharmaceutical Ingredient Product Overview
9.25.3 Tian Yao Active Pharmaceutical Ingredient Product Market Performance
9.25.4 Tian Yao Business Overview
9.25.5 Tian Yao Recent Developments
9.26 Lupin
9.26.1 Lupin Active Pharmaceutical Ingredient Basic Information
9.26.2 Lupin Active Pharmaceutical Ingredient Product Overview
9.26.3 Lupin Active Pharmaceutical Ingredient Product Market Performance
9.26.4 Lupin Business Overview
9.26.5 Lupin Recent Developments
9.27 North East Pharmaceutical
9.27.1 North East Pharmaceutical Active Pharmaceutical Ingredient Basic Information
9.27.2 North East Pharmaceutical Active Pharmaceutical Ingredient Product Overview
9.27.3 North East Pharmaceutical Active Pharmaceutical Ingredient Product Market Performance
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Active Pharmaceutical Ingredient Market Size (M USD) Comparison by Region (M USD)
Table 5. Global Active Pharmaceutical Ingredient Sales (K Units) by Manufacturers (2017-2022)
Table 6. Global Active Pharmaceutical Ingredient Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Active Pharmaceutical Ingredient Revenue (M USD) by Manufacturers (2017-2022)
Table 8. Global Active Pharmaceutical Ingredient Revenue Share by Manufacturers (2017-2022)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Active Pharmaceutical Ingredient as of 2021)
Table 10. Global Market Active Pharmaceutical Ingredient Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 11. Manufacturers Active Pharmaceutical Ingredient Sales Sites and Area Served
Table 12. Manufacturers Active Pharmaceutical Ingredient Product Type
Table 13. Global Active Pharmaceutical Ingredient Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Active Pharmaceutical Ingredient
Table 16. Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Active Pharmaceutical Ingredient Market Challenges
Table 22. Market Restraints
Table 23. Global Active Pharmaceutical Ingredient Sales by Type (K Units)
Table 24. Global Active Pharmaceutical Ingredient Market Size by Type (M USD)
Table 25. Global Active Pharmaceutical Ingredient Sales (K Units) by Type (2017-2022)
Table 26. Global Active Pharmaceutical Ingredient Sales Market Share by Type (2017-2022)
Table 27. Global Active Pharmaceutical Ingredient Market Size (M USD) by Type (2017-2022)
Table 28. Global Active Pharmaceutical Ingredient Market Size Share by Type (2017-2022)
Table 29. Global Active Pharmaceutical Ingredient Price (USD/Unit) by Type (2017-2022)
Table 30. Global Active Pharmaceutical Ingredient Sales (K Units) by Application
Table 31. Global Active Pharmaceutical Ingredient Market Size by Application
Table 32. Global Active Pharmaceutical Ingredient Sales by Application (2017-2022) & (K Units)
Table 33. Global Active Pharmaceutical Ingredient Sales Market Share by Application (2017-2022)
Table 34. Global Active Pharmaceutical Ingredient Sales by Application (2017-2022) & (M USD)
Table 35. Global Active Pharmaceutical Ingredient Market Share by Application (2017-2022)
Table 36. Global Active Pharmaceutical Ingredient Sales Growth Rate by Application (2017-2022)
Table 37. Global Active Pharmaceutical Ingredient Sales by Region (2017-2022) & (K Units)
Table 38. Global Active Pharmaceutical Ingredient Sales Market Share by Region (2017-2022)
Table 39. North America Active Pharmaceutical Ingredient Sales by Country (2017-2022) & (K Units)
Table 40. Europe Active Pharmaceutical Ingredient Sales by Country (2017-2022) & (K Units)
Table 41. Asia Pacific Active Pharmaceutical Ingredient Sales by Region (2017-2022) & (K Units)
Table 42. South America Active Pharmaceutical Ingredient Sales by Country (2017-2022) & (K Units)
Table 43. Middle East and Africa Active Pharmaceutical Ingredient Sales by Region (2017-2022) & (K Units)
Table 44. Teva Active Pharmaceutical Ingredient Basic Information
Table 45. Teva Active Pharmaceutical Ingredient Product Overview
Table 46. Teva Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 47. Teva Business Overview
Table 48. Teva Active Pharmaceutical Ingredient SWOT Analysis
Table 49. Teva Recent Developments
Table 50. Novartis Active Pharmaceutical Ingredient Basic Information
Table 51. Novartis Active Pharmaceutical Ingredient Product Overview
Table 52. Novartis Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 53. Novartis Business Overview
Table 54. Novartis Active Pharmaceutical Ingredient SWOT Analysis
Table 55. Novartis Recent Developments
Table 56. Pfizer Active Pharmaceutical Ingredient Basic Information
Table 57. Pfizer Active Pharmaceutical Ingredient Product Overview
Table 58. Pfizer Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 59. Pfizer Business Overview
Table 60. Pfizer Active Pharmaceutical Ingredient SWOT Analysis
Table 61. Pfizer Recent Developments
Table 62. Johnson and Johnson Active Pharmaceutical Ingredient Basic Information
Table 63. Johnson and Johnson Active Pharmaceutical Ingredient Product Overview
Table 64. Johnson and Johnson Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Johnson and Johnson Business Overview
Table 66. Johnson and Johnson Active Pharmaceutical Ingredient SWOT Analysis
Table 67. Johnson and Johnson Recent Developments
Table 68. Mylan Active Pharmaceutical Ingredient Basic Information
Table 69. Mylan Active Pharmaceutical Ingredient Product Overview
Table 70. Mylan Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 71. Mylan Business Overview
Table 72. Mylan Active Pharmaceutical Ingredient SWOT Analysis
Table 73. Mylan Recent Developments
Table 74. North China Pharmaceutical Group Active Pharmaceutical Ingredient Basic Information
Table 75. North China Pharmaceutical Group Active Pharmaceutical Ingredient Product Overview
Table 76. North China Pharmaceutical Group Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. North China Pharmaceutical Group Business Overview
Table 78. North China Pharmaceutical Group Recent Developments
Table 79. Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Basic Information
Table 80. Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Product Overview
Table 81. Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. Dr. Reddy’s Laboratories Business Overview
Table 83. Dr. Reddy’s Laboratories Recent Developments
Table 84. Roche Active Pharmaceutical Ingredient Basic Information
Table 85. Roche Active Pharmaceutical Ingredient Product Overview
Table 86. Roche Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. Roche Business Overview
Table 88. Roche Recent Developments
Table 89. Aurobindo pharma Active Pharmaceutical Ingredient Basic Information
Table 90. Aurobindo pharma Active Pharmaceutical Ingredient Product Overview
Table 91. Aurobindo pharma Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. Aurobindo pharma Business Overview
Table 93. Aurobindo pharma Recent Developments
Table 94. Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Basic Information
Table 95. Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Product Overview
Table 96. Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price
(USD/Unit) and Gross Margin (2017-2022)
Table 97. Sun Pharmaceutical Industries Business Overview
Table 98. Sun Pharmaceutical Industries Recent Developments
Table 99. Boehringer Ingelheim GmbH Active Pharmaceutical Ingredient Basic Information
Table 100. Boehringer Ingelheim GmbH Active Pharmaceutical Ingredient Product Overview
Table 101. Boehringer Ingelheim GmbH Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 102. Boehringer Ingelheim GmbH Business Overview
Table 103. Boehringer Ingelheim GmbH Recent Developments
Table 104. Bayer Active Pharmaceutical Ingredient Basic Information
Table 105. Bayer Active Pharmaceutical Ingredient Product Overview
Table 106. Bayer Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 107. Bayer Business Overview
Table 108. Bayer Recent Developments
Table 109. BASF Active Pharmaceutical Ingredient Basic Information
Table 110. BASF Active Pharmaceutical Ingredient Product Overview
Table 111. BASF Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 112. BASF Business Overview
Table 113. BASF Recent Developments
Table 114. DSM Active Pharmaceutical Ingredient Basic Information
Table 115. DSM Active Pharmaceutical Ingredient Product Overview
Table 116. DSM Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 117. DSM Business Overview
Table 118. DSM Recent Developments
Table 119. Zhejiang Medicine Active Pharmaceutical Ingredient Basic Information
Table 120. Zhejiang Medicine Active Pharmaceutical Ingredient Product Overview
Table 121. Zhejiang Medicine Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 122. Zhejiang Medicine Business Overview
Table 123. Zhejiang Medicine Recent Developments
Table 124. Biocon Active Pharmaceutical Ingredient Basic Information
Table 125. Biocon Active Pharmaceutical Ingredient Product Overview
Table 126. Biocon Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 127. Biocon Business Overview
Table 128. Biocon Recent Developments
Table 129. Johnson Matthey Active Pharmaceutical Ingredient Basic Information
Table 130. Johnson Matthey Active Pharmaceutical Ingredient Product Overview
Table 131. Johnson Matthey Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 132. Johnson Matthey Business Overview
Table 133. Johnson Matthey Recent Developments
Table 134. Hisun Pharmacy Active Pharmaceutical Ingredient Basic Information
Table 135. Hisun Pharmacy Active Pharmaceutical Ingredient Product Overview
Table 136. Hisun Pharmacy Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 137. Hisun Pharmacy Business Overview
Table 138. Hisun Pharmacy Recent Developments
Table 139. Cambrex Active Pharmaceutical Ingredient Basic Information
Table 140. Cambrex Active Pharmaceutical Ingredient Product Overview
Table 141. Cambrex Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 142. Cambrex Business Overview
Table 143. Cambrex Recent Developments
Table 144. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient Basic Information
Table 145. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient Product Overview
Table 146. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 147. Shandong Xinhua Pharmaceutical Business Overview
Table 148. Shandong Xinhua Pharmaceutical Recent Developments
Table 149. Lonza group Active Pharmaceutical Ingredient Basic Information
Table 150. Lonza group Active Pharmaceutical Ingredient Product Overview
Table 151. Lonza group Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 152. Lonza group Business Overview
Table 153. Lonza group Recent Developments
Table 154. Huahai Pharmaceutical Active Pharmaceutical Ingredient Basic Information
Table 155. Huahai Pharmaceutical Active Pharmaceutical Ingredient Product Overview
Table 156. Huahai Pharmaceutical Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 157. Huahai Pharmaceutical Business Overview
Table 158. Huahai Pharmaceutical Recent Developments
Table 159. Haerbin Pharmaceutical Group Active Pharmaceutical Ingredient Basic Information
Table 160. Haerbin Pharmaceutical Group Active Pharmaceutical Ingredient Product Overview
Table 161. Haerbin Pharmaceutical Group Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 162. Haerbin Pharmaceutical Group Business Overview
Table 163. Haerbin Pharmaceutical Group Recent Developments
Table 164. Cipla Active Pharmaceutical Ingredient Basic Information
Table 165. Cipla Active Pharmaceutical Ingredient Product Overview
Table 166. Cipla Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 167. Cipla Business Overview
Table 168. Cipla Recent Developments
Table 169. Tian Yao Active Pharmaceutical Ingredient Basic Information
Table 170. Tian Yao Active Pharmaceutical Ingredient Product Overview
Table 171. Tian Yao Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 172. Tian Yao Business Overview
Table 173. Tian Yao Recent Developments
Table 174. Lupin Active Pharmaceutical Ingredient Basic Information
Table 175. Lupin Active Pharmaceutical Ingredient Product Overview
Table 176. Lupin Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 177. Lupin Business Overview
Table 178. Lupin Recent Developments
Table 179. North East Pharmaceutical Active Pharmaceutical Ingredient Basic Information
Table 180. North East Pharmaceutical Active Pharmaceutical Ingredient Product Overview
Table 181. North East Pharmaceutical Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 182. North East Pharmaceutical Business Overview
Table 183. North East Pharmaceutical Recent Developments
Table 184. Albemarle Active Pharmaceutical Ingredient Basic Information
Table 185. Albemarle Active Pharmaceutical Ingredient Product Overview
Table 186. Albemarle Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 187. Albemarle Business Overview
Table 188. Albemarle Recent Developments
Table 189. Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredient Basic Information
Table 190. Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredient Product Overview
Table 191. Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 192. Shandong Lukang Pharmaceutical Business Overview
Table 193. Shandong Lukang Pharmaceutical Recent Developments
Table 194. Jiangsu?Hengrui Medicine Active Pharmaceutical Ingredient Basic Information
Table 195. Jiangsu?Hengrui Medicine Active Pharmaceutical Ingredient Product Overview
Table 196. Jiangsu?Hengrui Medicine Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 197. Jiangsu?Hengrui Medicine Business Overview
Table 198. Jiangsu?Hengrui Medicine Recent Developments
Table 199. Global Active Pharmaceutical Ingredient Sales Forecast by Region (K Units)
Table 200. Global Active Pharmaceutical Ingredient Market Size Forecast by Region (M USD)
Table 201. North America Active Pharmaceutical Ingredient Sales Forecast by Country (2022-2028) & (K Units)
Table 202. North America Active Pharmaceutical Ingredient Market Size Forecast by Country (2022-2028) & (M USD)
Table 203. Europe Active Pharmaceutical Ingredient Sales Forecast by Country (2022-2028) & (K Units)
Table 204. Europe Active Pharmaceutical Ingredient Market Size Forecast by Country (2022-2028) & (M USD)
Table 205. Asia Pacific Active Pharmaceutical Ingredient Sales Forecast by Region (2022-2028) & (K Units)
Table 206. Asia Pacific Active Pharmaceutical Ingredient Market Size Forecast by Region (2022-2028) & (M USD)
Table 207. South America Active Pharmaceutical Ingredient Sales Forecast by Country (2022-2028) & (K Units)
Table 208. South America Active Pharmaceutical Ingredient Market Size Forecast by Country (2022-2028) & (M USD)
Table 209. Middle East and Africa Active Pharmaceutical Ingredient Consumption Forecast by Country (2022-2028) & (Units)
Table 210. Middle East and Africa Active Pharmaceutical Ingredient Market Size Forecast by Country (2022-2028) & (M USD)
Table 211. Global Active Pharmaceutical Ingredient Sales Forecast by Type (2022-2028) & (K Units)
Table 212. Global Active Pharmaceutical Ingredient Market Size Forecast by Type (2022-2028) & (M USD)
Table 213. Global Active Pharmaceutical Ingredient Price Forecast by Type (2022-2028) & (USD/Unit)
Table 214. Global Active Pharmaceutical Ingredient Sales (K Units) Forecast by Application (2022-2028)
Table 215. Global Active Pharmaceutical Ingredient Market Size Forecast by Application (2022-2028) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Active Pharmaceutical Ingredient
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Active Pharmaceutical Ingredient Market Size (M USD), 2017-2028
Figure 5. Global Active Pharmaceutical Ingredient Market Size (M USD) (2017-2028)
Figure 6. Global Active Pharmaceutical Ingredient Sales (K Units) & (2017-2028)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Active Pharmaceutical Ingredient Market Size (M USD) by Country (M USD)
Figure 11. Active Pharmaceutical Ingredient Sales Share by Manufacturers in 2020
Figure 12. Global Active Pharmaceutical Ingredient Revenue Share by Manufacturers in 2020
Figure 13. Active Pharmaceutical Ingredient Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 14. Global Market Active Pharmaceutical Ingredient Average Price (USD/Unit) of Key Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Players: Market Share by Active Pharmaceutical Ingredient Revenue in 2021
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Active Pharmaceutical Ingredient Market Share by Type
Figure 18. Sales Market Share of Active Pharmaceutical Ingredient by Type (2017-2022)
Figure 19. Sales Market Share of Active Pharmaceutical Ingredient by Type in 2021
Figure 20. Market Size Share of Active Pharmaceutical Ingredient by Type (2017-2022)
Figure 21. Market Size Market Share of Active Pharmaceutical Ingredient by Type in 2020
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Active Pharmaceutical Ingredient Market Share by Application
Figure 24. Global Active Pharmaceutical Ingredient Sales Market Share by Application (2017-2022)
Figure 25. Global Active Pharmaceutical Ingredient Sales Market Share by Application in 2021
Figure 26. Global Active Pharmaceutical Ingredient Market Share by Application (2017-2022)
Figure 27. Global Active Pharmaceutical Ingredient Market Share by Application in 2020
Figure 28. Global Active Pharmaceutical Ingredient Sales Growth Rate by Application (2017-2022)
Figure 29. Global Active Pharmaceutical Ingredient Sales Market Share by Region (2017-2022)
1.1 Market Definition and Statistical Scope of Active Pharmaceutical Ingredient
1.2 Key Market Segments
1.2.1 Active Pharmaceutical Ingredient Segment by Type
1.2.2 Active Pharmaceutical Ingredient Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ACTIVE PHARMACEUTICAL INGREDIENT MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Active Pharmaceutical Ingredient Market Size (M USD) Estimates and Forecasts (2017-2028)
2.1.2 Global Active Pharmaceutical Ingredient Sales Estimates and Forecasts (2017-2028)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ACTIVE PHARMACEUTICAL INGREDIENT MARKET COMPETITIVE LANDSCAPE
3.1 Global Active Pharmaceutical Ingredient Sales by Manufacturers (2017-2022)
3.2 Global Active Pharmaceutical Ingredient Revenue Market Share by Manufacturers (2017-2022)
3.3 Active Pharmaceutical Ingredient Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Active Pharmaceutical Ingredient Average Price by Manufacturers (2017-2022)
3.5 Manufacturers Active Pharmaceutical Ingredient Sales Sites, Area Served, Product Type
3.6 Active Pharmaceutical Ingredient Market Competitive Situation and Trends
3.6.1 Active Pharmaceutical Ingredient Market Concentration Rate
3.6.2 Global 5 and 10 Largest Active Pharmaceutical Ingredient Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ACTIVE PHARMACEUTICAL INGREDIENT INDUSTRY CHAIN ANALYSIS
4.1 Active Pharmaceutical Ingredient Industry Chain Analysis
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ACTIVE PHARMACEUTICAL INGREDIENT MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ACTIVE PHARMACEUTICAL INGREDIENT MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Active Pharmaceutical Ingredient Sales Market Share by Type (2017-2022)
6.3 Global Active Pharmaceutical Ingredient Market Size Market Share by Type (2017-2022)
6.4 Global Active Pharmaceutical Ingredient Price by Type (2017-2022)
7 ACTIVE PHARMACEUTICAL INGREDIENT MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Active Pharmaceutical Ingredient Market Sales by Application (2017-2022)
7.3 Global Active Pharmaceutical Ingredient Market Size (M USD) by Application (2017-2022)
7.4 Global Active Pharmaceutical Ingredient Sales Growth Rate by Application (2017-2022)
8 ACTIVE PHARMACEUTICAL INGREDIENT MARKET SEGMENTATION BY REGION
8.1 Global Active Pharmaceutical Ingredient Sales by Region
8.1.1 Global Active Pharmaceutical Ingredient Sales by Region
8.1.2 Global Active Pharmaceutical Ingredient Sales Market Share by Region
8.2 North America
8.2.1 North America Active Pharmaceutical Ingredient Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Active Pharmaceutical Ingredient Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Active Pharmaceutical Ingredient Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Active Pharmaceutical Ingredient Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Active Pharmaceutical Ingredient Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILED
9.1 Teva
9.1.1 Teva Active Pharmaceutical Ingredient Basic Information
9.1.2 Teva Active Pharmaceutical Ingredient Product Overview
9.1.3 Teva Active Pharmaceutical Ingredient Product Market Performance
9.1.4 Teva Business Overview
9.1.5 Teva Active Pharmaceutical Ingredient SWOT Analysis
9.1.6 Teva Recent Developments
9.2 Novartis
9.2.1 Novartis Active Pharmaceutical Ingredient Basic Information
9.2.2 Novartis Active Pharmaceutical Ingredient Product Overview
9.2.3 Novartis Active Pharmaceutical Ingredient Product Market Performance
9.2.4 Novartis Business Overview
9.2.5 Novartis Active Pharmaceutical Ingredient SWOT Analysis
9.2.6 Novartis Recent Developments
9.3 Pfizer
9.3.1 Pfizer Active Pharmaceutical Ingredient Basic Information
9.3.2 Pfizer Active Pharmaceutical Ingredient Product Overview
9.3.3 Pfizer Active Pharmaceutical Ingredient Product Market Performance
9.3.4 Pfizer Business Overview
9.3.5 Pfizer Active Pharmaceutical Ingredient SWOT Analysis
9.3.6 Pfizer Recent Developments
9.4 Johnson and Johnson
9.4.1 Johnson and Johnson Active Pharmaceutical Ingredient Basic Information
9.4.2 Johnson and Johnson Active Pharmaceutical Ingredient Product Overview
9.4.3 Johnson and Johnson Active Pharmaceutical Ingredient Product Market Performance
9.4.4 Johnson and Johnson Business Overview
9.4.5 Johnson and Johnson Active Pharmaceutical Ingredient SWOT Analysis
9.4.6 Johnson and Johnson Recent Developments
9.5 Mylan
9.5.1 Mylan Active Pharmaceutical Ingredient Basic Information
9.5.2 Mylan Active Pharmaceutical Ingredient Product Overview
9.5.3 Mylan Active Pharmaceutical Ingredient Product Market Performance
9.5.4 Mylan Business Overview
9.5.5 Mylan Active Pharmaceutical Ingredient SWOT Analysis
9.5.6 Mylan Recent Developments
9.6 North China Pharmaceutical Group
9.6.1 North China Pharmaceutical Group Active Pharmaceutical Ingredient Basic Information
9.6.2 North China Pharmaceutical Group Active Pharmaceutical Ingredient Product Overview
9.6.3 North China Pharmaceutical Group Active Pharmaceutical Ingredient Product Market Performance
9.6.4 North China Pharmaceutical Group Business Overview
9.6.5 North China Pharmaceutical Group Recent Developments
9.7 Dr. Reddy’s Laboratories
9.7.1 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Basic Information
9.7.2 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Product Overview
9.7.3 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Product Market Performance
9.7.4 Dr. Reddy’s Laboratories Business Overview
9.7.5 Dr. Reddy’s Laboratories Recent Developments
9.8 Roche
9.8.1 Roche Active Pharmaceutical Ingredient Basic Information
9.8.2 Roche Active Pharmaceutical Ingredient Product Overview
9.8.3 Roche Active Pharmaceutical Ingredient Product Market Performance
9.8.4 Roche Business Overview
9.8.5 Roche Recent Developments
9.9 Aurobindo pharma
9.9.1 Aurobindo pharma Active Pharmaceutical Ingredient Basic Information
9.9.2 Aurobindo pharma Active Pharmaceutical Ingredient Product Overview
9.9.3 Aurobindo pharma Active Pharmaceutical Ingredient Product Market Performance
9.9.4 Aurobindo pharma Business Overview
9.9.5 Aurobindo pharma Recent Developments
9.10 Sun Pharmaceutical Industries
9.10.1 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Basic Information
9.10.2 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Product Overview
9.10.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Product Market Performance
9.10.4 Sun Pharmaceutical Industries Business Overview
9.10.5 Sun Pharmaceutical Industries Recent Developments
9.11 Boehringer Ingelheim GmbH
9.11.1 Boehringer Ingelheim GmbH Active Pharmaceutical Ingredient Basic Information
9.11.2 Boehringer Ingelheim GmbH Active Pharmaceutical Ingredient Product Overview
9.11.3 Boehringer Ingelheim GmbH Active Pharmaceutical Ingredient Product Market Performance
9.11.4 Boehringer Ingelheim GmbH Business Overview
9.11.5 Boehringer Ingelheim GmbH Recent Developments
9.12 Bayer
9.12.1 Bayer Active Pharmaceutical Ingredient Basic Information
9.12.2 Bayer Active Pharmaceutical Ingredient Product Overview
9.12.3 Bayer Active Pharmaceutical Ingredient Product Market Performance
9.12.4 Bayer Business Overview
9.12.5 Bayer Recent Developments
9.13 BASF
9.13.1 BASF Active Pharmaceutical Ingredient Basic Information
9.13.2 BASF Active Pharmaceutical Ingredient Product Overview
9.13.3 BASF Active Pharmaceutical Ingredient Product Market Performance
9.13.4 BASF Business Overview
9.13.5 BASF Recent Developments
9.14 DSM
9.14.1 DSM Active Pharmaceutical Ingredient Basic Information
9.14.2 DSM Active Pharmaceutical Ingredient Product Overview
9.14.3 DSM Active Pharmaceutical Ingredient Product Market Performance
9.14.4 DSM Business Overview
9.14.5 DSM Recent Developments
9.15 Zhejiang Medicine
9.15.1 Zhejiang Medicine Active Pharmaceutical Ingredient Basic Information
9.15.2 Zhejiang Medicine Active Pharmaceutical Ingredient Product Overview
9.15.3 Zhejiang Medicine Active Pharmaceutical Ingredient Product Market Performance
9.15.4 Zhejiang Medicine Business Overview
9.15.5 Zhejiang Medicine Recent Developments
9.16 Biocon
9.16.1 Biocon Active Pharmaceutical Ingredient Basic Information
9.16.2 Biocon Active Pharmaceutical Ingredient Product Overview
9.16.3 Biocon Active Pharmaceutical Ingredient Product Market Performance
9.16.4 Biocon Business Overview
9.16.5 Biocon Recent Developments
9.17 Johnson Matthey
9.17.1 Johnson Matthey Active Pharmaceutical Ingredient Basic Information
9.17.2 Johnson Matthey Active Pharmaceutical Ingredient Product Overview
9.17.3 Johnson Matthey Active Pharmaceutical Ingredient Product Market Performance
9.17.4 Johnson Matthey Business Overview
9.17.5 Johnson Matthey Recent Developments
9.18 Hisun Pharmacy
9.18.1 Hisun Pharmacy Active Pharmaceutical Ingredient Basic Information
9.18.2 Hisun Pharmacy Active Pharmaceutical Ingredient Product Overview
9.18.3 Hisun Pharmacy Active Pharmaceutical Ingredient Product Market Performance
9.18.4 Hisun Pharmacy Business Overview
9.18.5 Hisun Pharmacy Recent Developments
9.19 Cambrex
9.19.1 Cambrex Active Pharmaceutical Ingredient Basic Information
9.19.2 Cambrex Active Pharmaceutical Ingredient Product Overview
9.19.3 Cambrex Active Pharmaceutical Ingredient Product Market Performance
9.19.4 Cambrex Business Overview
9.19.5 Cambrex Recent Developments
9.20 Shandong Xinhua Pharmaceutical
9.20.1 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient Basic Information
9.20.2 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient Product Overview
9.20.3 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient Product Market Performance
9.20.4 Shandong Xinhua Pharmaceutical Business Overview
9.20.5 Shandong Xinhua Pharmaceutical Recent Developments
9.21 Lonza group
9.21.1 Lonza group Active Pharmaceutical Ingredient Basic Information
9.21.2 Lonza group Active Pharmaceutical Ingredient Product Overview
9.21.3 Lonza group Active Pharmaceutical Ingredient Product Market Performance
9.21.4 Lonza group Business Overview
9.21.5 Lonza group Recent Developments
9.22 Huahai Pharmaceutical
9.22.1 Huahai Pharmaceutical Active Pharmaceutical Ingredient Basic Information
9.22.2 Huahai Pharmaceutical Active Pharmaceutical Ingredient Product Overview
9.22.3 Huahai Pharmaceutical Active Pharmaceutical Ingredient Product Market Performance
9.22.4 Huahai Pharmaceutical Business Overview
9.22.5 Huahai Pharmaceutical Recent Developments
9.23 Haerbin Pharmaceutical Group
9.23.1 Haerbin Pharmaceutical Group Active Pharmaceutical Ingredient Basic Information
9.23.2 Haerbin Pharmaceutical Group Active Pharmaceutical Ingredient Product Overview
9.23.3 Haerbin Pharmaceutical Group Active Pharmaceutical Ingredient Product Market Performance
9.23.4 Haerbin Pharmaceutical Group Business Overview
9.23.5 Haerbin Pharmaceutical Group Recent Developments
9.24 Cipla
9.24.1 Cipla Active Pharmaceutical Ingredient Basic Information
9.24.2 Cipla Active Pharmaceutical Ingredient Product Overview
9.24.3 Cipla Active Pharmaceutical Ingredient Product Market Performance
9.24.4 Cipla Business Overview
9.24.5 Cipla Recent Developments
9.25 Tian Yao
9.25.1 Tian Yao Active Pharmaceutical Ingredient Basic Information
9.25.2 Tian Yao Active Pharmaceutical Ingredient Product Overview
9.25.3 Tian Yao Active Pharmaceutical Ingredient Product Market Performance
9.25.4 Tian Yao Business Overview
9.25.5 Tian Yao Recent Developments
9.26 Lupin
9.26.1 Lupin Active Pharmaceutical Ingredient Basic Information
9.26.2 Lupin Active Pharmaceutical Ingredient Product Overview
9.26.3 Lupin Active Pharmaceutical Ingredient Product Market Performance
9.26.4 Lupin Business Overview
9.26.5 Lupin Recent Developments
9.27 North East Pharmaceutical
9.27.1 North East Pharmaceutical Active Pharmaceutical Ingredient Basic Information
9.27.2 North East Pharmaceutical Active Pharmaceutical Ingredient Product Overview
9.27.3 North East Pharmaceutical Active Pharmaceutical Ingredient Product Market Performance
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Active Pharmaceutical Ingredient Market Size (M USD) Comparison by Region (M USD)
Table 5. Global Active Pharmaceutical Ingredient Sales (K Units) by Manufacturers (2017-2022)
Table 6. Global Active Pharmaceutical Ingredient Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Active Pharmaceutical Ingredient Revenue (M USD) by Manufacturers (2017-2022)
Table 8. Global Active Pharmaceutical Ingredient Revenue Share by Manufacturers (2017-2022)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Active Pharmaceutical Ingredient as of 2021)
Table 10. Global Market Active Pharmaceutical Ingredient Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 11. Manufacturers Active Pharmaceutical Ingredient Sales Sites and Area Served
Table 12. Manufacturers Active Pharmaceutical Ingredient Product Type
Table 13. Global Active Pharmaceutical Ingredient Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Active Pharmaceutical Ingredient
Table 16. Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Active Pharmaceutical Ingredient Market Challenges
Table 22. Market Restraints
Table 23. Global Active Pharmaceutical Ingredient Sales by Type (K Units)
Table 24. Global Active Pharmaceutical Ingredient Market Size by Type (M USD)
Table 25. Global Active Pharmaceutical Ingredient Sales (K Units) by Type (2017-2022)
Table 26. Global Active Pharmaceutical Ingredient Sales Market Share by Type (2017-2022)
Table 27. Global Active Pharmaceutical Ingredient Market Size (M USD) by Type (2017-2022)
Table 28. Global Active Pharmaceutical Ingredient Market Size Share by Type (2017-2022)
Table 29. Global Active Pharmaceutical Ingredient Price (USD/Unit) by Type (2017-2022)
Table 30. Global Active Pharmaceutical Ingredient Sales (K Units) by Application
Table 31. Global Active Pharmaceutical Ingredient Market Size by Application
Table 32. Global Active Pharmaceutical Ingredient Sales by Application (2017-2022) & (K Units)
Table 33. Global Active Pharmaceutical Ingredient Sales Market Share by Application (2017-2022)
Table 34. Global Active Pharmaceutical Ingredient Sales by Application (2017-2022) & (M USD)
Table 35. Global Active Pharmaceutical Ingredient Market Share by Application (2017-2022)
Table 36. Global Active Pharmaceutical Ingredient Sales Growth Rate by Application (2017-2022)
Table 37. Global Active Pharmaceutical Ingredient Sales by Region (2017-2022) & (K Units)
Table 38. Global Active Pharmaceutical Ingredient Sales Market Share by Region (2017-2022)
Table 39. North America Active Pharmaceutical Ingredient Sales by Country (2017-2022) & (K Units)
Table 40. Europe Active Pharmaceutical Ingredient Sales by Country (2017-2022) & (K Units)
Table 41. Asia Pacific Active Pharmaceutical Ingredient Sales by Region (2017-2022) & (K Units)
Table 42. South America Active Pharmaceutical Ingredient Sales by Country (2017-2022) & (K Units)
Table 43. Middle East and Africa Active Pharmaceutical Ingredient Sales by Region (2017-2022) & (K Units)
Table 44. Teva Active Pharmaceutical Ingredient Basic Information
Table 45. Teva Active Pharmaceutical Ingredient Product Overview
Table 46. Teva Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 47. Teva Business Overview
Table 48. Teva Active Pharmaceutical Ingredient SWOT Analysis
Table 49. Teva Recent Developments
Table 50. Novartis Active Pharmaceutical Ingredient Basic Information
Table 51. Novartis Active Pharmaceutical Ingredient Product Overview
Table 52. Novartis Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 53. Novartis Business Overview
Table 54. Novartis Active Pharmaceutical Ingredient SWOT Analysis
Table 55. Novartis Recent Developments
Table 56. Pfizer Active Pharmaceutical Ingredient Basic Information
Table 57. Pfizer Active Pharmaceutical Ingredient Product Overview
Table 58. Pfizer Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 59. Pfizer Business Overview
Table 60. Pfizer Active Pharmaceutical Ingredient SWOT Analysis
Table 61. Pfizer Recent Developments
Table 62. Johnson and Johnson Active Pharmaceutical Ingredient Basic Information
Table 63. Johnson and Johnson Active Pharmaceutical Ingredient Product Overview
Table 64. Johnson and Johnson Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Johnson and Johnson Business Overview
Table 66. Johnson and Johnson Active Pharmaceutical Ingredient SWOT Analysis
Table 67. Johnson and Johnson Recent Developments
Table 68. Mylan Active Pharmaceutical Ingredient Basic Information
Table 69. Mylan Active Pharmaceutical Ingredient Product Overview
Table 70. Mylan Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 71. Mylan Business Overview
Table 72. Mylan Active Pharmaceutical Ingredient SWOT Analysis
Table 73. Mylan Recent Developments
Table 74. North China Pharmaceutical Group Active Pharmaceutical Ingredient Basic Information
Table 75. North China Pharmaceutical Group Active Pharmaceutical Ingredient Product Overview
Table 76. North China Pharmaceutical Group Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. North China Pharmaceutical Group Business Overview
Table 78. North China Pharmaceutical Group Recent Developments
Table 79. Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Basic Information
Table 80. Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Product Overview
Table 81. Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. Dr. Reddy’s Laboratories Business Overview
Table 83. Dr. Reddy’s Laboratories Recent Developments
Table 84. Roche Active Pharmaceutical Ingredient Basic Information
Table 85. Roche Active Pharmaceutical Ingredient Product Overview
Table 86. Roche Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. Roche Business Overview
Table 88. Roche Recent Developments
Table 89. Aurobindo pharma Active Pharmaceutical Ingredient Basic Information
Table 90. Aurobindo pharma Active Pharmaceutical Ingredient Product Overview
Table 91. Aurobindo pharma Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. Aurobindo pharma Business Overview
Table 93. Aurobindo pharma Recent Developments
Table 94. Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Basic Information
Table 95. Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Product Overview
Table 96. Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price
(USD/Unit) and Gross Margin (2017-2022)
Table 97. Sun Pharmaceutical Industries Business Overview
Table 98. Sun Pharmaceutical Industries Recent Developments
Table 99. Boehringer Ingelheim GmbH Active Pharmaceutical Ingredient Basic Information
Table 100. Boehringer Ingelheim GmbH Active Pharmaceutical Ingredient Product Overview
Table 101. Boehringer Ingelheim GmbH Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 102. Boehringer Ingelheim GmbH Business Overview
Table 103. Boehringer Ingelheim GmbH Recent Developments
Table 104. Bayer Active Pharmaceutical Ingredient Basic Information
Table 105. Bayer Active Pharmaceutical Ingredient Product Overview
Table 106. Bayer Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 107. Bayer Business Overview
Table 108. Bayer Recent Developments
Table 109. BASF Active Pharmaceutical Ingredient Basic Information
Table 110. BASF Active Pharmaceutical Ingredient Product Overview
Table 111. BASF Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 112. BASF Business Overview
Table 113. BASF Recent Developments
Table 114. DSM Active Pharmaceutical Ingredient Basic Information
Table 115. DSM Active Pharmaceutical Ingredient Product Overview
Table 116. DSM Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 117. DSM Business Overview
Table 118. DSM Recent Developments
Table 119. Zhejiang Medicine Active Pharmaceutical Ingredient Basic Information
Table 120. Zhejiang Medicine Active Pharmaceutical Ingredient Product Overview
Table 121. Zhejiang Medicine Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 122. Zhejiang Medicine Business Overview
Table 123. Zhejiang Medicine Recent Developments
Table 124. Biocon Active Pharmaceutical Ingredient Basic Information
Table 125. Biocon Active Pharmaceutical Ingredient Product Overview
Table 126. Biocon Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 127. Biocon Business Overview
Table 128. Biocon Recent Developments
Table 129. Johnson Matthey Active Pharmaceutical Ingredient Basic Information
Table 130. Johnson Matthey Active Pharmaceutical Ingredient Product Overview
Table 131. Johnson Matthey Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 132. Johnson Matthey Business Overview
Table 133. Johnson Matthey Recent Developments
Table 134. Hisun Pharmacy Active Pharmaceutical Ingredient Basic Information
Table 135. Hisun Pharmacy Active Pharmaceutical Ingredient Product Overview
Table 136. Hisun Pharmacy Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 137. Hisun Pharmacy Business Overview
Table 138. Hisun Pharmacy Recent Developments
Table 139. Cambrex Active Pharmaceutical Ingredient Basic Information
Table 140. Cambrex Active Pharmaceutical Ingredient Product Overview
Table 141. Cambrex Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 142. Cambrex Business Overview
Table 143. Cambrex Recent Developments
Table 144. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient Basic Information
Table 145. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient Product Overview
Table 146. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 147. Shandong Xinhua Pharmaceutical Business Overview
Table 148. Shandong Xinhua Pharmaceutical Recent Developments
Table 149. Lonza group Active Pharmaceutical Ingredient Basic Information
Table 150. Lonza group Active Pharmaceutical Ingredient Product Overview
Table 151. Lonza group Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 152. Lonza group Business Overview
Table 153. Lonza group Recent Developments
Table 154. Huahai Pharmaceutical Active Pharmaceutical Ingredient Basic Information
Table 155. Huahai Pharmaceutical Active Pharmaceutical Ingredient Product Overview
Table 156. Huahai Pharmaceutical Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 157. Huahai Pharmaceutical Business Overview
Table 158. Huahai Pharmaceutical Recent Developments
Table 159. Haerbin Pharmaceutical Group Active Pharmaceutical Ingredient Basic Information
Table 160. Haerbin Pharmaceutical Group Active Pharmaceutical Ingredient Product Overview
Table 161. Haerbin Pharmaceutical Group Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 162. Haerbin Pharmaceutical Group Business Overview
Table 163. Haerbin Pharmaceutical Group Recent Developments
Table 164. Cipla Active Pharmaceutical Ingredient Basic Information
Table 165. Cipla Active Pharmaceutical Ingredient Product Overview
Table 166. Cipla Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 167. Cipla Business Overview
Table 168. Cipla Recent Developments
Table 169. Tian Yao Active Pharmaceutical Ingredient Basic Information
Table 170. Tian Yao Active Pharmaceutical Ingredient Product Overview
Table 171. Tian Yao Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 172. Tian Yao Business Overview
Table 173. Tian Yao Recent Developments
Table 174. Lupin Active Pharmaceutical Ingredient Basic Information
Table 175. Lupin Active Pharmaceutical Ingredient Product Overview
Table 176. Lupin Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 177. Lupin Business Overview
Table 178. Lupin Recent Developments
Table 179. North East Pharmaceutical Active Pharmaceutical Ingredient Basic Information
Table 180. North East Pharmaceutical Active Pharmaceutical Ingredient Product Overview
Table 181. North East Pharmaceutical Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 182. North East Pharmaceutical Business Overview
Table 183. North East Pharmaceutical Recent Developments
Table 184. Albemarle Active Pharmaceutical Ingredient Basic Information
Table 185. Albemarle Active Pharmaceutical Ingredient Product Overview
Table 186. Albemarle Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 187. Albemarle Business Overview
Table 188. Albemarle Recent Developments
Table 189. Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredient Basic Information
Table 190. Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredient Product Overview
Table 191. Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 192. Shandong Lukang Pharmaceutical Business Overview
Table 193. Shandong Lukang Pharmaceutical Recent Developments
Table 194. Jiangsu?Hengrui Medicine Active Pharmaceutical Ingredient Basic Information
Table 195. Jiangsu?Hengrui Medicine Active Pharmaceutical Ingredient Product Overview
Table 196. Jiangsu?Hengrui Medicine Active Pharmaceutical Ingredient Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 197. Jiangsu?Hengrui Medicine Business Overview
Table 198. Jiangsu?Hengrui Medicine Recent Developments
Table 199. Global Active Pharmaceutical Ingredient Sales Forecast by Region (K Units)
Table 200. Global Active Pharmaceutical Ingredient Market Size Forecast by Region (M USD)
Table 201. North America Active Pharmaceutical Ingredient Sales Forecast by Country (2022-2028) & (K Units)
Table 202. North America Active Pharmaceutical Ingredient Market Size Forecast by Country (2022-2028) & (M USD)
Table 203. Europe Active Pharmaceutical Ingredient Sales Forecast by Country (2022-2028) & (K Units)
Table 204. Europe Active Pharmaceutical Ingredient Market Size Forecast by Country (2022-2028) & (M USD)
Table 205. Asia Pacific Active Pharmaceutical Ingredient Sales Forecast by Region (2022-2028) & (K Units)
Table 206. Asia Pacific Active Pharmaceutical Ingredient Market Size Forecast by Region (2022-2028) & (M USD)
Table 207. South America Active Pharmaceutical Ingredient Sales Forecast by Country (2022-2028) & (K Units)
Table 208. South America Active Pharmaceutical Ingredient Market Size Forecast by Country (2022-2028) & (M USD)
Table 209. Middle East and Africa Active Pharmaceutical Ingredient Consumption Forecast by Country (2022-2028) & (Units)
Table 210. Middle East and Africa Active Pharmaceutical Ingredient Market Size Forecast by Country (2022-2028) & (M USD)
Table 211. Global Active Pharmaceutical Ingredient Sales Forecast by Type (2022-2028) & (K Units)
Table 212. Global Active Pharmaceutical Ingredient Market Size Forecast by Type (2022-2028) & (M USD)
Table 213. Global Active Pharmaceutical Ingredient Price Forecast by Type (2022-2028) & (USD/Unit)
Table 214. Global Active Pharmaceutical Ingredient Sales (K Units) Forecast by Application (2022-2028)
Table 215. Global Active Pharmaceutical Ingredient Market Size Forecast by Application (2022-2028) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Active Pharmaceutical Ingredient
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Active Pharmaceutical Ingredient Market Size (M USD), 2017-2028
Figure 5. Global Active Pharmaceutical Ingredient Market Size (M USD) (2017-2028)
Figure 6. Global Active Pharmaceutical Ingredient Sales (K Units) & (2017-2028)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Active Pharmaceutical Ingredient Market Size (M USD) by Country (M USD)
Figure 11. Active Pharmaceutical Ingredient Sales Share by Manufacturers in 2020
Figure 12. Global Active Pharmaceutical Ingredient Revenue Share by Manufacturers in 2020
Figure 13. Active Pharmaceutical Ingredient Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 14. Global Market Active Pharmaceutical Ingredient Average Price (USD/Unit) of Key Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Players: Market Share by Active Pharmaceutical Ingredient Revenue in 2021
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Active Pharmaceutical Ingredient Market Share by Type
Figure 18. Sales Market Share of Active Pharmaceutical Ingredient by Type (2017-2022)
Figure 19. Sales Market Share of Active Pharmaceutical Ingredient by Type in 2021
Figure 20. Market Size Share of Active Pharmaceutical Ingredient by Type (2017-2022)
Figure 21. Market Size Market Share of Active Pharmaceutical Ingredient by Type in 2020
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Active Pharmaceutical Ingredient Market Share by Application
Figure 24. Global Active Pharmaceutical Ingredient Sales Market Share by Application (2017-2022)
Figure 25. Global Active Pharmaceutical Ingredient Sales Market Share by Application in 2021
Figure 26. Global Active Pharmaceutical Ingredient Market Share by Application (2017-2022)
Figure 27. Global Active Pharmaceutical Ingredient Market Share by Application in 2020
Figure 28. Global Active Pharmaceutical Ingredient Sales Growth Rate by Application (2017-2022)
Figure 29. Global Active Pharmaceutical Ingredient Sales Market Share by Region (2017-2022)
